| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Assurance Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S$0.0005 |
| 52 Week High | S$0.11 |
| 52 Week Low | S$0.0005 |
| Beta | -0.63 |
| 11 Month Change | 0% |
| 3 Month Change | -90.00% |
| 1 Year Change | 0% |
| 33 Year Change | -99.62% |
| 5 Year Change | n/a |
| Change since IPO | -99.59% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7IQ | DE IT | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.0% | 1.5% |
| 1Y | 0% | -14.3% | 6.2% |
Return vs Industry: 7IQ exceeded the German IT industry which returned -14.3% over the past year.
Return vs Market: 7IQ underperformed the German Market which returned 6.2% over the past year.
Price Volatility
| 7IQ volatility | |
|---|---|
| 7IQ Average Weekly Movement | 667.5% |
| IT Industry Average Movement | 4.6% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 7IQ's share price has been volatile over the past 3 months.
Volatility Over Time: 7IQ's weekly volatility has decreased from 5815% to 668% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 30 | n/a | www.revezcorp.com |
Assurance Healthcare Limited, together with its subsidiaries, engages in the technology related solutions in Singapore. It operates through IT Solutions; Meetings, Incentive, Conferences, Exhibitions; and Digital Media Networks segments. The company offers solutions in the areas of immersive multimedia, information and communication technology, cybersecurity, and digital media networks.
Assurance Healthcare Limited Fundamentals Summary
| 7IQ fundamental statistics | |
|---|---|
| Market cap | €7.30m |
| Earnings (TTM) | -€70.96k |
| Revenue (TTM) | n/a |
-8.5x
P/S Ratio-102.9x
P/E RatioIs 7IQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7IQ income statement (TTM) | |
|---|---|
| Revenue | -S$1.23m |
| Cost of Revenue | -S$1.30m |
| Gross Profit | S$65.87k |
| Other Expenses | S$168.21k |
| Earnings | -S$102.34k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00039 |
| Gross Margin | -5.35% |
| Net Profit Margin | 8.31% |
| Debt/Equity Ratio | 2.9% |
How did 7IQ perform over the long term?
See historical performance and comparison